COMP <GO>
KYMR vs TWST // EV/EBITDA & P/E VALUATION
Kymera Therapeutics Inc. (NASDAQ) VS. Twist Bioscience Corporation (NASDAQ) • 15-METRIC TALLY: KYMR 2
— TWST 8
■ METRIC PARITY
LAST: $126.63 (+3.29%) • MKT CAP: $10.19B
valuation
—
LAST: $152.78 (-11.92%) • MKT CAP: $11.50B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KYMR VS. TWST)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KYMR | TWST | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 94.20% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -21.40% | -11.70% | -9.70 | TWST | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.30% | -0.66% | -1.64 | TWST | /fcf-yield <GO> |
| Operating Margin | -60.00% | -4.20% | -55.80 | TWST | /operating-margins <GO> |
| Net Profit Margin | 68.00% | -2.40% | +70.40 | KYMR | /net-margins <GO> |
| Revenue Growth (YoY) | -16.70% | 16.50% | -33.20 | TWST | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 26.00 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 6/9 | -2.00 | TWST | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.6 | 57.2 | +4.40 | KYMR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 0.98 | -0.03 | TWST | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.4x | 21.0x | +9.40 | TWST | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.19B | $11.50B | -$1.31B | TWST | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KYMR REV | TWST REV | KYMR GROSS % | TWST GROSS % | KYMR FCF | TWST FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $39.2M | $0 | 0.0% | — | -$234.3M | -$75.6M |
| FY 2024 | $47.1M | $0 | 0.0% | — | -$207.3M | -$69.2M |
| FY 2023 | $78.6M | $0 | — | — | -$106.4M | -$142.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KYMR // BETA 0.95
TWST // BETA 0.98